- Practice your BMRN trading strategies and win cash in our stock game.
NEW YORK ( TheStreet) -- BioMarin Pharmaceuticals Inc (Nasdaq: BMRN) hit a new 52-week high Friday as it is currently trading at $33.55, above its previous 52-week high of $33.50 with 290,888 shares traded as of 2:06 p.m. ET. Average volume has been 1.2 million shares over the past 30 days. BioMarin has a market cap of $3.6 billion and is part of the health care sector and drugs industry. Shares are up 24.3% year to date as of the close of trading on Thursday. BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions. Its product portfolio comprises approved products and multiple investigational product candidates. The company has a P/E ratio of 17.1, below the average drugs industry P/E ratio of 20.6 and below the S&P 500 P/E ratio of 17.7.